PCN111 - COST ESTIMATE OF IMMUNE-RELATED ADVERSE REACTIONS ASSOCIATED WITH INNOVATIVE TREATMENTS OF METASTATIC MELANOMA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.194
https://www.valueinhealthjournal.com/article/S1098-3015(18)33494-6/fulltext
Title :
PCN111 - COST ESTIMATE OF IMMUNE-RELATED ADVERSE REACTIONS ASSOCIATED WITH INNOVATIVE TREATMENTS OF METASTATIC MELANOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33494-6&doi=10.1016/j.jval.2018.09.194
First page :
Section Title :
Open access? :
No
Section Order :
1326